TG THERAPEUTICS, INC.

For the period ended Jun 11, 2026. Filed Jun 12, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Jun 11, 2026 · Filed Jun 12, 2026

Use the contents to explore the available documents and sections.

TGTX$59.83+3.2%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Proposal

Proposal 1

The votes with respect to the election of the six directors to hold office until the 2027 annual meeting were as follows:

Director	Votes For	% Voted For	Votes Withheld	% Voted Withheld	Broker Non-Votes
Michael S. Weiss	72,172,630	88.63%	9,260,279	11.37%	31,570,505
Laurence N. Charney	68,135,448	83.67%	13,297,461	16.33%	31,570,505
Yann Echelard	64,110,661	78.73%	17,322,248	21.27%	31,570,505
Kenneth Hoberman	53,354,717	65.52%	28,078,192	34.48%	31,570,505
Daniel Hume	63,979,535	78.57%	17,453,374	21.43%	31,570,505
Sagar Lonial, MD	44,666,544	54.85%	36,766,365	45.15%	31,570,505

Proposal 2

The vote with respect to the ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows:

Total Votes For	Total Votes Against	Abstentions	Broker Non-Votes
112,329,330	531,758	142,326	--

Proposal 3

The advisory vote to approve the compensation of the Company’s named executive officers was as follows:

Total Votes For	Total Votes Against	Abstentions	Broker Non-Votes
31,905,837	48,858,169	668,903	31,570,505

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.